個人檔案
學歷
- 2007 臺北醫學大學藥學系博士
- 2001 臺北醫學大學生物醫學技術研究所碩士
- 1999 臺北醫學大學醫事技術學系學士
經歷
- 2018.01- 臺北醫學大學生技醫療產業研發博士學位學程副研究員
- 2017.03- 臺北醫學大學癌症生物學與藥物研發博士學位學程助理研究員
- 2015.08- 臺北醫學大學醫學生物科技博士學位學程籌備處助理研究員
- 2017.02- 臺北醫學大學癌症轉譯研究中心副研究員
- 2014.09-2017.01 臺北醫學大學癌症轉譯研究中心助理研究員
- 2013.10-2014.09 臺北醫學大學癌症生物學與藥物研發博士學位學程專案助理教授
- 2013.03-2013.10 臺北醫學大學癌症生物學與藥物研發博士學位學程助理研究員
- 2008.01-2013.02 中央研究院博士後研究
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
-
標靶促紅血球生成素產生的肝細胞受體A2型於膽管癌治療之應用探討及同時靶向表皮生長因子受體的雙特異性交叉抗體開發研究(1/3)
Lee, Y.-C. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
利用自體抗體片段標靶特異性Gd-IgA1的基礎來開發做為IgA腎病變診斷與治療的策略
Lee, Y.-C. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
開發標靶促紅血球生成素產生的肝細胞受體A2型之抗體藥物複合體應用於胰臟癌的治療
Lee, Y.-C. (PI)
8/1/22 → 7/31/23
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
以IgA1 O-聯結醣基為標靶開發IgA腎病變之診斷試劑重塑臨床評估之準則(3/3)
Lee, Y.-C. (PI)
8/1/21 → 7/31/22
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
以IgA1 O-聯結醣基為標靶開發IgA腎病變之診斷試劑重塑臨床評估之準則(2/3)
Lee, Y.-C. (PI)
8/1/20 → 7/31/22
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
Impact of humanization scaffold design on the functional activity of FGFR2-targeting chicken scFvs
Yii, S. C., Lin, T. Y., Chang, F. L., Jaw, F. S., Tsai, K. C., Lin, Y. S. & Lee, Y. C., 1月 2026, 於: Journal of Biotechnology. 409, p. 57-66 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Apple polyphenol phloretin inhibits type II glucose transporter and enhances anti-HER2 antibody drug binding as an adjuvant treatment for HER2-positive breast cancer
Chang, H. S., Cheng, T. C., Tu, S. H., Liao, P. H., Lee, Y. C., Ho, C. T., Pan, M. H., Chen, L. C. & Ho, Y. S., 4月 2025, 於: Food Science and Human Wellness. 14, 4, 9250251.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Correction to: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients (Biomarker Research, (2025), 13, 1, (7), 10.1186/s40364-024-00715-5)
Cheng, T. C., Hung, M. C., Wang, L. H., Tu, S. H., Wu, C. H., Yen, Y., Chen, C. L., Whang-Peng, J., Lee, W. J., Liao, Y. C., Lee, Y. C., Pan, M. H., Lin, H. K., Tzeng, H. E., Guo, P., Chu, C. Y., Chen, L. C. & Ho, Y. S., 12月 2025, 於: Biomarker Research. 13, 1, 100.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients
Cheng, T.-C., Hung, M.-C., Wang, L.-H., Tu, S.-H., Wu, C.-H., Yen, Y., Chen, C.-L., Whang-Peng, J., Lee, W.-J., Liao, Y.-C., Lee, Y.-C., Pan, M.-H., Lin, H.-K., Tzeng, H.-E., Guo, P., Chu, C.-Y. & Chen, L.-C., 1月 9 2025, 於: Biomarker Research. 13, 1, p. 7 7.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取3 !!Link opens in a new tab 引文 斯高帕斯（Scopus） -
Prediction of Coronary Artery Spasm in Patients Without Obstructive Coronary Artery Disease Using a Comprehensive Clinical, Laboratory and Echocardiographic Risk Score
Lee, Y. C., Chen, I. Y., Hung, M. J., Yeh, C. T., Kounis, N. G., Hu, P. & Hung, M. Y., 12月 2025, 於: Journal of Clinical Medicine. 14, 24, 8721.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 !!Link opens in a new tab 引文 斯高帕斯（Scopus）
資料集
-
Chicken antibodies against venom proteins of Trimeresurus stejnegeri in Taiwan
Lee, C.-H. (Contributor), Liu, C.-I. (Contributor), Leu, S.-J. (Contributor), Lee, Y.-C. (Contributor), Chiang, J.-R. (Contributor), Chiang, L.-C. (Contributor), Mao, Y.-C. (Contributor), Tsai, B.-Y. (Contributor), Hung, C.-S. (Contributor), Chen, C.-C. (Contributor) & Yang, Y.-Y. (Creator), SciELO journals, 2021
DOI: 10.6084/m9.figshare.14287411.v1, https://scielo.figshare.com/articles/dataset/Chicken_antibodies_against_venom_proteins_of_Trimeresurus_stejnegeri_in_Taiwan/14287411/1
資料集: Dataset
-
Additional file 2 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Huang, H.-L. (Contributor), HuangFu, W.-C. (Creator), Cheng, Y.-W. (Creator), Cheng, C.-C. (Creator), Chang, F.-L. (Creator), Sung, T.-Y. (Creator), Pan, S.-L. (Creator), Lee, Y.-C. (Contributor), Wei, P.-L. (Contributor) & Huang, C.-C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14228281.v1, https://doi.org/10.6084%2Fm9.figshare.14228281.v1
資料集: Dataset
-
Additional file 3 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
HuangFu, W.-C. (Creator), Sung, T.-Y. (Creator), Lee, Y.-C. (Contributor), Pan, S.-L. (Creator), Cheng, Y.-W. (Creator), Chang, F.-L. (Creator), Wei, P.-L. (Contributor), Huang, C.-C. (Contributor), Huang, H.-L. (Contributor) & Cheng, C.-C. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.14228284.v1, https://doi.org/10.6084%2Fm9.figshare.14228284.v1
資料集: Dataset
-
Additional file 1 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Cheng, Y.-W. (Creator), Cheng, C.-C. (Creator), HuangFu, W.-C. (Creator), Pan, S.-L. (Creator), Sung, T.-Y. (Creator), Chang, F.-L. (Creator), Huang, H.-L. (Contributor), Huang, C.-C. (Contributor), Wei, P.-L. (Contributor) & Lee, Y.-C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14228278.v1, https://doi.org/10.6084%2Fm9.figshare.14228278.v1
資料集: Dataset
-
EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Sung, T.-Y. (Creator), Huang, H.-L. (Contributor), Cheng, C.-C. (Creator), Chang, F.-L. (Creator), Wei, P.-L. (Contributor), Cheng, Y.-W. (Creator), Huang, C.-C. (Contributor), Lee, Y.-C. (Contributor), HuangFu, W.-C. (Creator) & Pan, S.-L. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5341486.v1, https://springernature.figshare.com/collections/EGFL6_promotes_colorectal_cancer_cell_growth_and_mobility_and_the_anti_cancer_property_of_anti-EGFL6_antibody/5341486/1
資料集: Dataset